Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kenneth Tyler to Natalizumab

This is a "connection" page, showing publications Kenneth Tyler has written about Natalizumab.

 
Connection Strength
 
 
 
0.882
 
  1. Tyler KL, Vollmer TL. To PLEX or not to PLEX in natalizumab-associated PML. Neurology. 2017 03 21; 88(12):1108-1109.
    View in: PubMed
    Score: 0.581
  2. Clifford DB, Tyler KL. Dosing interval of natalizumab in MS: Do good things come to those who wait? Neurology. 2019 10 08; 93(15):655-656.
    View in: PubMed
    Score: 0.173
  3. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005 Jul 28; 353(4):369-74.
    View in: PubMed
    Score: 0.065
  4. Tyler KL, Khalili K. Natalizumab and progressive multifocal leukoencephalopathy: highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA. Rev Neurol Dis. 2005; 2(3):144-9.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)